| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-15 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |